NEXGEL, INC. NXGL
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-12-22
NEXGEL, INC. statistics & valuation
Market cap$6.1M
P / S0.5×
P / B1.3×
Net margin-26.3%
Return on equity-61.3%
FCF margin-12.1%
Net debt$588,000
Enterprise value USD$6.7M
Earnings yield EBIT/EV-49.8%
Return on capital-44.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 39.5% | 31.6% | 9.1% | 12.5% | 0.5% | -43.2% | -19.1% | 23.2% |
| Operating margin | -29.3% | -40.9% | -85.0% | -163.5% | -165.7% | -335.3% | -268.3% | -85.3% |
| Net margin | -26.3% | -37.8% | -77.2% | -231.7% | -277.9% | -335.9% | -268.2% | -85.3% |
| FCF margin | -12.1% | -49.6% | -96.2% | -150.8% | -194.8% | -313.5% | -253.0% | — |
| Return on assets | -28.7% | -29.9% | -31.7% | -45.8% | -25.4% | -100.3% | -101.7% | -255.5% |
| Return on equity | -61.3% | -54.0% | -61.1% | -62.1% | -35.7% | -3188.7% | -506.1% | -671.9% |
| Debt / equity | 0.12× | 0.11× | 0.11× | 0.04× | — | — | — | — |
| Current ratio | 1.47 | 2.07 | 1.98 | 8.74 | 4.82 | 0.27 | 0.64 | 0.89 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.